Acad. Sci. USA 74, 764-7681 on the purification and characterization of the DNA polymerase from human breast cancer particles. Its preference for certain synthetic templates and its ability to use a viral RNA to fashion a faithful DNA transcript identify it as a reverse transcriptase similar to that found in the mouse mammary tumor virus and in the Mason-Pfizer monkey virus (MPMV). We report here that the human breast cancer enzyme crossreacts immunologically with the reverse transcriptase of MPMV. The crossreactivity was shown both by inhibition of enzyme activity and by complex formation between purified enzyme and isolated IgG against MPMV polymerase. No such interactions were observed with other oncornavirus reverse transcriptases of avian, murine, feline, or simian origin. Further, the IgG failed to neutralize the reverse transcriptases from human mesenchymal neoplasias (leukemias and lymphomas) or the activities of normal cellular DNA polymerases (a, A, y).
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Previous studies (1-7) have identified human breast tumor particles that exhibit many of the features characteristic of RNA tumor viruses. In addition to the expected size (600 S) and density (1.16 g/ml), these particles have an outer membrane and an inner one surrounding a "core" containing a DNA polymerase (deoxynucleosidetriphosphate:DNA deoxynucleotidyltransferase, EC 2.7.7.7) (reverse transcriptase) complexed to a large (70 S) RNA exhibiting detectable homology to the RNAs of the mouse mammary tumor virus and of the Mason-Pfizer monkey virus (MPMV). The DNA polymerase of human breast cancer particles has been purified (8) as a 70,000-dalton protein with the following three features that together serve to distinguish viral reverse transcriptases from the known animal cellular DNA polymerases: (i) a strong preference for oligo(dT)-poly(rA) over oligo(dT)-poly(dA) as a template for the synthesis of poly(dT); (ii) the acceptance of the specific oligo(dG)-poly(rCm) as a template for the synthesis of poly(dG); and (iii) the ability to use a viral RNA (avian myeloblastosis virus) as a template to fashion a faithful DNA complementary copy.
The present investigation focuses on the antigenic properties of the human breast cancer reverse transcriptase with particular emphasis on possible crossreactivities with animal viral reverse transcriptases. This type of immunologic information has been used by tumor virologists to classify the oncogenic RNA viruses into the following distinct groups: (i) the avian leukemia-sarcoma viruses (9) (10) (11) ; (ii) the subprimate leukemia-sarcoma viruses (9) (10) (11) (12) (13) (14) ; (iii) the nonhuman primate leukemia-sarcoma viruses (11, 13, 14) ; (iv) the mouse mammary tumor virus (9, 10, 12) ; and (v) a unique group composed of the MPMV and its close relatives (15) .
In addition to its biologic and evolutionary implications, the identification of antigenic relationships among oncogenic agents from different species can generate useful immunologic reagents for the detection of viruses or their protein components. In particular, a demonstration of an antigenic relationship between a protein of the virus-like particles found in human neoplasias and a corresponding protein of a known animal virus could bypass the logistic difficulties of obtaining purified human particle proteins in the amounts required to produce the relevant antisera. This in turn could permit the development of a potentially useful diagnostic tool. Thus far, attempts along these lines have been confined to the leukemias. The reverse transcriptase found in leukemic cells has in some instances (16, 17) been neutralized by antibodies prepared against the reverse transcriptases of woolly monkey sarcoma virus and the gibbon ape leukemia virus.
We report here that the reverse transcriptase purified from human breast cancer particles crossreacts with antibodies produced by immunizing rabbits with purified reverse transcriptase of the MPMV isolated from a spontaneous mammary tumor of a rhesus monkey (4) .
MATERIALS AND METHODS
Viruses. MPMV was propagated in a suspension culture of the normal human lymphocytic cell line NC-37 and concentrated at the J. L. Smith Memorial for Cancer Research (Pfizer, Inc.) as previously described (18 Preparation of Viral Regions from Human Leukemia and Hodgkin's Lymphoma Spleen. Spleens from patients with human chronic lymphocytic leukemia, chronic myelogenous leukemia, or Hodgkin's lymphoma were used as the sources of viral density region preparations, and the polymerase activities were analyzed by endogenous kinetics as described (19) .
Preparation of MPMV Polymerase. The MPMV pellet prepared as described above was resuspended in 0.05 M Tris.
HCl, pH 9.2/0.001 M EDTA/2 M KC1, sonicated, and then centrifuged at 98,000 X g for 120 min. The pellet was used to prepare purified DNA polymerase by column chromatography as described previously (19) .
Preparation of Antiserum. Antiserum against MPMV DNA was induced in New Zealand White rabbits. Three cycles of immunization were required to achieve the desired titer of anti-polymerase IgG. In each cycle the enzyme (1 X 103 pmol of TMP incorporated per min) was emulsified with an equal volume of Freund's adjuvant and injected into the two hind footpads. This was followed by two additional similar inoculations given at 2-week intervals in the same sites.
Serum samples were fractionated by chromatography on a Sephadex G-200 with 0.1 M Tris-HCl, pH 8.0. Rabbit gamma globulins were identified serologically by immunodiffusion with goat antiserum to rabbit IgG. The relevant fractions were concentrated by ammonium sulfate precipitation (50% saturation) and dialyzed against 0.1 M Tris*HCI, pH 8 .0. The protein concentration of the IgG fraction was measured by the Lowry procedure (20) .
DNA Polymerase Assays. Assay mixtures for polymerase activity with synthetic polymer templates contained (in 100 Ml) 5 All reactions were incubated at 360 for 15-30 min as indicated and were terminated by the addition of 0.5 ml of cold 0.067 M sodium pyrophosphate/1 M sodium phosphate, pH 7.2, followed by 0.5 ml of cold 80% (vol/vol) trichloroacetic acid. Acid-insoluble radioactivity was collected on membrane filters and measured in a scintillation counter.
Terminal deoxynucleotide transferase activity was measured by the polymerization of [3H]dGTP in the absence of a complementary polymer template, the latter being replaced by 0. Detection of Antibody-Enzyme Complexes in Glycerol Gradients. The concentrated enzyme (reverse transcriptase from MPMV or from human malignant breast tumors) fractions were diluted with 2 volumes of 0.1 M potassium phosphate, pH 8.0, containing bovine serum albumin (0.5 mg/ml), and the indicated amounts of purified IgG fractions were added. After incubation for 15 min at 40, the samples were layered over a 10-30% glycerol gradient adjusted to 0.1 M potassium phosphate (pH 8.0), 0.002 M dithiothreitol, and 0.02% Triton X-100. The samples were sedimented at 48,000 rpm for 12 hr in a Spinco SW50-1 rotor at 10. Fractions were collected dropwise from the bottom of the tubes and the enzyme activity was assayed as described above.
RESULTS
Comparison of the Effects of Anti-MPMV DNA Polymerase IgG on Various Polymerases. In these experiments, isopycnically banded particles, purified as described in Materials and Methods, were used as a source of the DNA polymerase, and oligo(dG)-poly(rC) was used as the template. It is evident from Fig. 1 that the antibody inhibited the MPMV DNA polymerase more than 80% and achieved a 26% inhibition of the DNA polymerase associated with the human breast cancer particles. In contrast, no detectable effect was observed on the DNA polymerases of any of the other animal oncornaviruses, including avian myeloblastosis virus, Rauscher and Friend murine leukemia viruses, feline leukemia virus, a simian sarcoma virus, and murine mammary tumor virus.
Specificity of the Inhibition by the Anti-MPMV Poly- merase IgG. The next issue examined centered on whether the inhibition observed with the breast cancer particle enzyme was confined to this malignancy. As we have shown previously (19) , spleens from patients with mesenchymal cancers constitute a convenient source of particle enzyme, and these were chosen for immunologic comparison. The particle fractions were prepared and the endogenous polymerase activities were assayed as previously described for human breast tumors (6, 8) and for spleens involved in mesenchymal neoplasias (19 lines could identify the basis underlying the apparent inability of the anti-MPMV DNA polymerase IgG to achieve total neutralization of the breast cancer reverse transcriptase activity. Basically, two mechanisms can be offered to explain the incompleteness of the inhibition. One is that the enzyme preparation is heterogeneous and that only a subpopulation forms inactive complexes with the added IgG. The other is that the population of enzyme molecules is homogeneous in this respect and that all form complexes which can, however, express a fraction of the original activity. These two possibilities are readily distinguishable by a sedimentation analysis of the enzyme activity before and after reaction with the relevant IgG.
To monitor the effectiveness of this approach, a positive control experiment was carried out with the homologous system consisting of MPMV DNA polymerase and its antibody. IgG from the same rabbit. The 250-i, reaction mixture containing enzyme and 150 Atg of the indicated IgG was incubated at 40 for 15 min as described in Materials and Methods. The mixture was then layered on a 10-30% gradient and centrifuged at 48,000 rpm in a Spinco SW50-1 rotor for 12 hr at 10. Fractions were collected from the bottom of the tube and assayed for reverse transcriptase and for the presence of IgG by immunodiffusion. As shown in Fig. 3A , incubation with normal IgG did not change the position (tube 13) of the peak of MPMV reverse transcriptase activity with respect to the external marker, bovine serum albumin. The enzyme still sedimented at a velocity corresponding to a molecular weight of 70,000. In this same gradient, the IgG was located in tubes 10, 11, and 12. Incubation of the polymerase with 150 ,g of anti-MPMV polymerase resulted in an 80% loss of enzyme activity and a markedly different sedimentation pattern of the residual activity. No enzyme was detectable at the original position close to bovine serum albumin, all of it appearing as complexes sedimenting faster than free enzyme or IgG. The IgG was detected by immunodiffusion in fractions 13, 14 , and 15 as well as in fractions 6 through 10 which encompass the peak of polymerase activity.
A similar situation occurred in the experiments, described in Fig. 4 , with the reverse transcriptase purified from human breast cancer particles. Incubation with normal IgG (Fig. 4A ) left the human enzyme in its usual position (tube 15) , within one tube of the marker, and the IgG was found by immunodiffusion in tubes 12 to 14. However, reaction with anti-MPMV polymerase IgG resulted in a 45% loss of activity and shifted the residue down the tube as fast-moving complexes found in fractions 6 through 10 in which IgG also was detected by immunodiffusion (Fig. 4B) . IgG also was found in its original position (fractions 12 through 14) .
It is evident from the results described in Figs. 3 and 4 that neither the MPMV reverse transcriptase nor the one isolated from human breast cancer particles contains a significant proportion of molecules unable to complex with anti-MPMV polymerase IgG. The fact that the enzyme-IgG complexes can express some activity is not a new phenomenon. Indeed, in some reported instances such complexes are fully active (21) and this property was used to develop a convenient immunoprecipitation of specific ribosomes carrying newly synthesized chains of specific proteins (22) .
DISCUSSION
The experiments described here show that anti-MPMV DNA polymerase IgG, when present in excess, can completely complex with and partially inhibit the reverse transcriptase isolated from human breast cancer particles. The specificity of the inhibition is supported by the inability of this same antibody to affect the activities of normal cellular DNA polymerases or of various reverse transcriptases from animal oncornaviruses. Further, normal IgG obtained from the same rabbit prior to immunization does not complex with or inhibit either the MPMV or the human breast cancer reverse transcriptase.
Aside from its etiologic interest, the immunologic crossreactivity between the reverse transcriptases of MPMV and of the human breast cancer particles has an implication of more immediate import. It suggests the existence of a novel pathway for examining human breast cancer 
